Standout Papers

Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy 2022 2026 2023 2024341
  1. Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy (2022)
    Fan Yang, Yi Xiao et al. Cell Metabolism
  2. Advances in targeting histone deacetylase for treatment of solid tumors (2024)
    Ying Xu, Xin Fu et al. Journal of Hematology & Oncology

Immediate Impact

1 by Nobel laureates 5 from Science/Nature 57 standout
Sub-graph 1 of 23

Citing Papers

Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
2025 Standout
Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment
2025 Standout
1 intermediate paper

Works of Yi Xiao being referenced

Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy
2022 Standout
Synergism between fludarabine and rituximab revealed in a follicular lymphoma cell line resistant to the cytotoxic activity of either drug alone
2001

Author Peers

Author Last Decade Papers Cites
Yi Xiao 780 582 484 41 1.6k
Mei‐Chih Liang 1289 357 698 30 2.1k
Wei Ji 1141 374 502 91 2.0k
Chellappagounder Thangavel 615 691 836 37 1.6k
Otília Menyhárt 1393 518 497 34 2.1k
Laura Moro 1133 308 432 55 2.2k
Jean-Marc Schlaeppi 1059 252 550 25 1.9k
Anette Sommer 1202 187 690 62 2.0k
Jeffrey Kiefer 1156 266 581 59 2.0k
Chirayu Goswami 1065 232 435 43 1.7k
John L. Darling 981 221 499 66 2.0k

All Works

Loading papers...

Rankless by CCL
2026